You just read:

Mallinckrodt Enrolls First Patient in Phase 2B Trial of H.P. Acthar® Gel (Repository Corticotropin Injection) for Amyotrophic Lateral Sclerosis (ALS)

News provided by

Mallinckrodt plc

Jun 14, 2017, 16:30 ET